Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Betaferon efficiency indicators in the treatment of relapsing remitting form of multiple sclerosis.
Immunomodulatory activity of interferon-beta.
Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis.
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
Hematopoietic Stem Cell Therapy for Multiple Sclerosis: Top 10 Lessons Learned.
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis.
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.
Antigen Microarrays for the Study of Autoimmune Diseases.
Color blindness among multiple sclerosis patients in Isfahan.
Retinal nerve fiber layer thickness in benign multiple sclerosis.
Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system.
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients.
Gene Therapy of Multiple Sclerosis Using Interferon β -Secreting Human Bone Marrow Mesenchymal Stem Cells.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
The two sides of pseudo-bulbar disorder in multiple sclerosis: Comparing one patient's experience with a review of the neurologic literature.
The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis.
Socioeconomic status. The relationship with health and autoimmune diseases.
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
Optic Neuritis, its Differential Diagnosis and Management.
Alemtuzumab for relapsing-remitting multiple sclerosis.
Impact of high intensity exercise on muscle morphology in EAE rats.
Interferon-β1a modulates glutamate neurotransmission in the CNS through CaMKII and GluN2A-containing NMDA receptors.
Experience with Fingolimod in Clinical Practice.
Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.

Pages